Úsek pro vědu a výzkum

Impaktované publikace

[41]

Markova, J.; Trnkova, Z.; Michkova, P.; Maaloufova, J.; Stary, J.; Cetkovsky, P.; Schwarz, J.

Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome

[rok vydání 2009, impact factor 2.397]

[42]

Polák, J.; Koza, V.; Cetkovský, P.; Haškovec, C.

An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene : the first case of transplanted CML with micro BCR

[rok vydání 2006, impact factor 2.396]

[43]

Pekova, S.; Ivanek, R.; Dvorak, M.; Rueggeberg, S.; Leicht, S.; Li, X.; Franzc, T.; Kozak, T.; Vrba, D.; Koza, V.; Karas, M.; Schwarz, J.; Cetkovsky, P.; Prucha, M.

Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells : implications for the biological properties of AML blasts

[rok vydání 2009, impact factor 2.358]

[44]

Klamová, H.; Marková, M.; Moravcová, J.; Šišková, M.; Cetkovský, P.; Machová Poláková, K.

Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery

[rok vydání 2009, impact factor 2.358]

[45]

Racil, Z.; Weinbergerova, B.; Kocmanova, I.; Muzik, J.; Kouba, M.; Drgona, L.; Masarova, L.; Guman, T.; Tothova, E.; Forsterova, K.; Haber, J.; Ziakova, B.; Bojtarova, E.; Vydra, J.; Mudry, P.; Foralova, R.; Sejnova, D.; Mallatova, N.; Kandrnal, V.; Cetkovsky, P.; Mayer, J.

Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak Republics: Fungal InfectioN Database (FIND) analysis, 2005-2009

[rok vydání 2012, impact factor 2.330 ]

[46]

Vydra, J.; Válková, V.; Čemusová, B.; Kolář, M.; Nováková, L.; Soukup, P.; Šálek, C.; Vraná, M.; Pytlík, R.; Lesný, P.; Vítek, A.; Cetkovský, P.; Marková, M.

Hematopoietic stem cell transplantation from haploidentical donors in aplasia after cladribine/cytarabine chemotherapy for refractory acute myeloid leukemia or myelodysplastic syndrome

[rok vydání 2019, impact factor 2.298 ]

[47]

Chrenkova, V.; Hubka, V.; Cetkovsky, P.; Kouba, M.; Weinbergerova, B.; Lyskova, P.; Hornofova, L.; Hubacek, P.

Proven invasive pulmonary aspergillosis in stem cell transplant recipient due to aspergillus sublatus, a cryptic species of A. nidulans

[rok vydání 2017, impact factor 2.278 ]

[48]

Vydra, J.; Šálek, C.; Schwarz, J.; Žák, P.; Novák, J.; Petečuková, V.; Pecherková, P.; Mayer, J.; Cetkovský, P.; Ráčil, Z.

Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission

[rok vydání 2017, impact factor 2.274 ]

[49]

Valkova, V.; Jircikova, J.; Trnkova, M.; Steinerova, K.; Keslova, P.; Lanska, M.; Koristek, Z.; Raida, L.; Krejci, M.; Kruntoradova, K.; Dolezal, T.; Benesova, K.; Cetkovsky, P.; Trneny, M.

The quality of life following allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

[rok vydání 2016, impact factor 1.871 ]

[50]

Jindra, P.; Mužík, J.; Indrák, K.; Žák, P.; Sabty, F.A.; Kozák, T.; Cetkovský, P.; Karas, M.; Raida, L.; Szotkowski, T.

The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients less or equal than 50 years from the Czech acute leukaemia clinical register (alert)

[rok vydání 2013, impact factor 1.642 ]

[51]

Válková, V.; Polák, J.; Marková, M.; Vítek, A.; Hájková, H.; Šálek, C.; Procházka, B.; Cetkovský, P.; Trněný, M.

Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis

[rok vydání 2012, impact factor 1.486 ]

[52]

Klamova, H.; Faber, E.; Zackova, D.; Markova, M.; Voglova, J.; Cmunt, E.; Novakova, L.; Machova-Polakova, K.; Moravcova, J.; Dvorakova, D.; Michalova, K.; Brezinova, J.; Oltova, A.; Jarosova, M.; Cetkovsky, P.; Indrak, K.; Mayer, J.

Dasatinib in imatinib-resistant or -intolerant CML patients : data from the clinical practice of 6 hematological centers in the Czech Republic

[rok vydání 2010, impact factor 1.449]

[53]

Racil, Z.; Winterova, J.; Kouba, M.; Zak, P.; Malaskova, L.; Buresova, L.; Toskova, M.; Lengerova, M.; Kocmanova, I.; Weinbergerova, B.; Timilsina, S.; Rolencova, M.; Cetkovsky, P.; Mayer, J.

Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience

[rok vydání 2012, impact factor 1.278 ]

[54]

Razga, F.; Racil, Z.; Machova Polakova, K.; Buresova, L.; Klamova, H.; Zackova, D.; Dvorakova, D.; Polivkova, V.; Cetkovsky, P.; Mayer, J.

The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia

[rok vydání 2012, impact factor 1.268 ]

[55]

Schwarz, J.; Mikulenková, D.; Čermáková, K.; Polanská, V.; Michalová, K.; Marinov, I.; Campr, V.; Ransdorfová, Š.; Marková, J.; Pavlištová, L.; Březinová, J.; Sajdová, J.; Šponerová, D.; Volková, Z.; Benešová, K.; Čermák, J.; Vítek, A.; Cetkovský, P.

Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia : correlations with IgVH gene mutational status and other prognostic markers

[rok vydání 2006, impact factor 1.247]

[56]

Doubek, M.; Muzik, J.; Szotkowski, T.; Koza, V.; Cetkovsky, P.; Kozak, T.; Zak, P.; Voglova, J.; Struncova, S.; Dusek, L.; Indrak, K.

Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? : an analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT)

[rok vydání 2007, impact factor 1.208]

[57]

Faber, E.; Koza, V.; Vitek, A.; Mayer, J.; Sedlacek, P.; Zak, P.; Zapletalova, J.; Benesova, K.; Krejcova, H.; Steinerova, K.; Maresova, I.; Cetkovsky, P.

Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning

[rok vydání 2008, impact factor 1.208]

[58]

Hubacek, P.; Hrdlickova, A.; Spacek, M.; Zajac, M.; Muzikova, K.; Sedlacek, P.; Cetkovsky, P.

Prevalence of chromosomally integrated HHV-6 in patients with malignant disease and healthy donors in the Czech Republic

[rok vydání 2012, impact factor 1.145 ]

[59]

Marinov, I.; Luxová, A.; Tkáčová, V.; Gašová, Z.; Pohlreich, D.; Cetkovský, P.

Comparison of three single platform methods for CD34+ hematopoietic stem cell enumeration by flow cytometry

[rok vydání 2012, impact factor 0.904]

[60]

Humlová, Z.; Klamová, H.; Janatková, I.; Šandová, P.; Šterzl, I.; Sobotková, E.; Hamšíková, E.; Haškovec, C.; Písačka, M.; Cetkovský, P.; Michalová, K.; Faber, E.; Heřmanová, Z.; Ordeltová, M.; Roubalová, K.; Roth, Z.; Vonka, V.

Immunological profiles of patients with chronic myeloid leukemia : I. state before the start of treatment

[rok vydání 2007, impact factor 0.387]